Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ICI-204-636' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    2. Woods, SW; Stolar, M; Sernyak, MJ; Charney, DS
      Consistency of atypical antipsychotic superiority to placebo in recent clinical trials

      BIOLOGICAL PSYCHIATRY
    3. Reznik, I; Benatov, R; Sirota, P
      Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    4. Matheson, AJ; Lamb, HM
      Quetiapine - A review of its clinical potential in the management of psychotic symptoms in Parkinson's disease

      CNS DRUGS
    5. Guan, HJ; Dai, J; Zhu, XZ
      Atypical antipsychotic effects of quetiapine fumarate in animal models

      ACTA PHARMACOLOGICA SINICA
    6. Yeung, PP; Tariot, PN; Schneider, LS; Salzman, C; Rak, IW
      Quetiapine for elderly patients with psychotic disorders

      PSYCHIATRIC ANNALS
    7. Copolov, DL; Link, CGG; Kowalcyk, B
      A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia

      PSYCHOLOGICAL MEDICINE
    8. Green, B
      Focus on quetiapine

      CURRENT MEDICAL RESEARCH AND OPINION
    9. Goldstein, JM
      Quetiapine fumarate (Seroquel (R)): A new atypical antipsychotic

      DRUGS OF TODAY
    10. GUNASEKARA NS; SPENCER CM
      QUETIAPINE - A REVIEW OF ITS USE IN SCHIZOPHRENIA

      CNS DRUGS
    11. CALEY CF; ROSENBAUM S
      FOCUS ON QUETIAPINE - THE 4TH ATYPICAL ANTIPSYCHOTIC

      Formulary
    12. PARSA MA; BASTANI B
      QUETIAPINE (SEROQUEL) IN THE TREATMENT OF PSYCHOSIS IN PATIENTS WITH PARKINSONS-DISEASE

      The Journal of neuropsychiatry and clinical neurosciences
    13. HARMON TJ; BENITEZ JG; KRENZELOK EP; CORTESBELEN E
      LOSS OF CONSCIOUSNESS FROM ACUTE QUETIAPINE OVERDOSAGE

      Journal of toxicology. Clinical toxicology
    14. GOREN JL; LEVIN GM
      QUETIAPINE, AN ATYPICAL ANTIPSYCHOTIC

      Pharmacotherapy
    15. KING DJ; LINK CGG; KOWALCYK B
      A COMPARISON OF BD AND TID DOSE REGIMENS OF QUETIAPINE (SEROQUEL) IN THE TREATMENT OF SCHIZOPHRENIA

      Psychopharmacology
    16. GOUDIE A; TAYLOR A
      COMPARATIVE CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF CLOZAPINE AND OTHER ANTIPSYCHOTICS IN RATS

      Psychopharmacology
    17. ARVANITIS LA; MILLER BG; BORISON RL; PITTS WM; SHARIF ZA; HAMNER MB; HERZ MI; TRUE JE; VELLIGAN D; KNESEVICH MA; SMALL J; STEINBOOK R; HERTZMAN M; KECK PE; NEWCOMER JW; GRACE J; ROTROSEN J; TANDON R; DOTT SG; FERGUSON JM; ADDINGTON DEN; MACEWAN GW; NAIR VNP; SHRIQUI CL; WILLIAMS R; DANIEL DG; SHEHI GM; PATTERSON WM; MERIDETH CH
      MULTIPLE FIXED DOSES OF SEROQUEL (QUETIAPINE) IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA - A COMPARISON WITH HALOPERIDOL AND PLACEBO

      Biological psychiatry
    18. KUFFERLE B; TAUSCHER J; ASENBAUM S; VESELY C; PODREKA I; BRUCKE T; KASPER S
      IBZM SPECT IMAGING OF STRIATAL DOPAMINE-2 RECEPTORS IN PSYCHOTIC-PATIENTS TREATED WITH THE NOVEL ANTIPSYCHOTIC SUBSTANCE QUETIAPINE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      Psychopharmacology
    19. ELLENBROEK BA; LUBBERS LJ; COOLS AR
      ACTIVITY OF SEROQUEL (ICI204,636) IN ANIMAL-MODELS FOR ATYPICAL PROPERTIES OF ANTIPSYCHOTICS - A COMPARISON WITH CLOZAPINE

      Neuropsychopharmacology
    20. ERESHEFSKY L
      PHARMACOKINETICS AND DRUG-INTERACTIONS - UPDATE FOR NEW ANTIPSYCHOTICS

      The Journal of clinical psychiatry
    21. DEVENEY AM; WADDINGTON JL
      COMPARISON OF THE NEW ATYPICAL ANTIPSYCHOTICS OLANZAPINE AND ICI-204,636 WITH CLOZAPINE ON BEHAVIORAL-RESPONSES TO THE SELECTIVE D-1 LIKE DOPAMINE-RECEPTOR AGONIST A-68930 AND SELECTIVE D-2-LIKE AGONIST RU-24213

      Psychopharmacology
    22. WETZEL H; SZEGEDI A; HAIN C; WIESNER J; SCHLEGEL S; BENKERT O
      SEROQUEL (ICI-204-636), A PUTATIVE ATYPICAL ANTIPSYCHOTIC, IN SCHIZOPHRENIA WITH POSITIVE SYMPTOMATOLOGY - RESULTS OF AN OPEN CLINICAL-TRIAL AND CHANGES OF NEUROENDOCRINOLOGICAL AND EEG PARAMETERS

      Psychopharmacology
    23. SALLER CF; SALAMA AI
      SEROQUEL - BIOCHEMICAL PROFILE OF A POTENTIAL ATYPICAL ANTIPSYCHOTIC

      Psychopharmacology
    24. GOLDSTEIN JM; LITWIN LC; SUTTON EB; MALICK JB
      SEROQUEL - ELECTROPHYSIOLOGICAL PROFILE OF A POTENTIAL ATYPICAL ANTIPSYCHOTIC

      Psychopharmacology
    25. MIGLER BM; WARAWA EJ; MALICK JB
      SEROQUEL - BEHAVIORAL-EFFECTS IN CONVENTIONAL AND NOVEL TESTS FOR ATYPICAL ANTIPSYCHOTIC DRUG

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 05:28:15